2015 Jan 28. pii: S0960-894X(15)00051-7. doi: 10.1016/j.bmcl.2015.01.039. [Epub ahead of print]
Del Prete D1, Caprioglio D1, Appendino G1, Minassi A2, Schiano-Moriello A3, Di Marzo V3, De Petrocellis L4.
Abstract
Replacement of the benzylamide motif of synthetic capsaicin (nonivamide, 1c) with a tetrazole moiety was detrimental for TRPV1 binding, but unexpectedly generated a potent and non-electrophilic TRPA1 agonist (4a). Spurred by this observation and by the relatively small number of non-covalent TRPA1 ligands reported so far, the benzylamide-to-tetrazole swap was investigated in the more lipophilic and powerful vanilloids olvanil (1d), rinvanil (1e), and phenylacetylrinvanil (1f). In all cases, the replacement was detrimental for TRPV1 binding, but a clear modulation of TRPA1 activity was observed. These observations show that the capsaicinoid pharmacophore displays orthogonal structure-activity relationships for TRPV1 and TRPA1 binding, and suggest the possibility of obtaining compounds with dual TRPV1/TRPA1 modulatory properties by exploration of the chemical space around the capsaicin motif.
Copyright © 2015 Elsevier Ltd. All rights reserved.
Copyright © 2015 Elsevier Ltd. All rights reserved.
KEYWORDS:
Capsaicin; Rinvanil; Structure–activity relationships; TRPA1; TRPV1
- PMID:
- 25666822
- [PubMed – as supplied by publisher]